<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2710211241
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2015
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NORMALIX SR 1.5 mg modified-release tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        INDAPAMIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        modified-release tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jazeera Pharmaceutical Industries (JPI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C03BA11
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Normalix SR is a prolonged-release film-coated tablets containing indapamide as active ingredient. This medicine is intended to reduce high blood pressure (hypertension) in adults. Indapamide is a diuretic. Most diuretics increase the amount of urine produced by the kidneys. However, indapamide is different from other diuretics, as it only causes a slight increase in the amount of urine produced.</p><p>&nbsp;</p><p>In addition, indapamide widens blood vessels so that blood passes through more easily. This helps to lower blood pressure.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Normalix SR </strong></p><ul><li>&nbsp; &nbsp; If you are allergic to indapamide or any other sulfonamide or to any of the other ingredients of this medicine (listed in section 6),&nbsp;</li><li>&nbsp; &nbsp; If you have severe kidney disease, &nbsp;</li><li>&nbsp; &nbsp; If you have severe liver disease or suffer from a condition called hepatic encephalopathy (degenerative disease of the brain),</li><li>&nbsp; &nbsp; If you have low potassium levels in your blood.</li></ul><p>&nbsp;</p><p><strong>Warnings and precautions </strong></p><p>Talk to your doctor or pharmacist before taking Normalix SR:</p><ul><li>&nbsp; &nbsp; If you have liver problems,</li><li>&nbsp; &nbsp; If you have diabetes,</li><li>&nbsp; &nbsp; If you suffer from gout,</li><li>&nbsp; &nbsp; If you have any heart rhythm problems or problems with your kidneys,</li><li>&nbsp; &nbsp; If you need to have a test to check how well your parathyroid gland is working,</li><li>&nbsp; &nbsp; If you experience a decrease in vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to a week of taking Normalix SR. This can lead to permanent vision loss, if not treated. If you earlier have had a penicillin or sulfonamide allergy, you can be at higher risk of developing this.</li></ul><p>&nbsp;</p><p>You should tell your doctor if you had photosensitivity reactions.</p><p>&nbsp;</p><p>Your doctor may give you blood tests to check for low sodium or potassium levels or high calcium levels. &nbsp;</p><p>&nbsp;</p><p>If you think any of these situations may apply to you or you have any questions or doubts about taking your medicine, you should consult your doctor or pharmacist.</p><p>Athletes should be aware that this medicine contains an active ingredient, which may give a positive reaction in doping tests.</p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and Normalix SR</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p>You should not take Normalix SR with lithium (used to treat depression) due to the risk of increased levels of lithium in the blood.</p><p>&nbsp;</p><p>Make sure to tell your doctor if you are taking any of the following medicines, as special care may be required:</p><ul><li>&nbsp; &nbsp; Medicines used for heart rhythm problems (e.g. quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, ibutilide, dofetilide, digitalis), &nbsp;</li><li>&nbsp; &nbsp; Medicines used to treat mental disorders such as depression, anxiety, schizophrenia&hellip; (e.g. tricyclic antidepressants, antipsychotic drugs, neuroleptics), &nbsp;</li><li>&nbsp; &nbsp; Bepridil (used to treat angina pectoris, a condition causing chest pain), &nbsp;</li><li>&nbsp; &nbsp; Cisapride, diphemanil (used to treat gastro-intestinal problems), &nbsp;</li><li>&nbsp; &nbsp; Sparfloxacin, moxifloxacin, erythromycin by injection (antibiotics used to treat infections), &nbsp;</li><li>&nbsp; &nbsp; Vincamine by injection (used to treat symptomatic cognitive disorders in elderly including memory loss), &nbsp;</li><li>&nbsp; &nbsp; Halofantrine (antiparasitic drug used to treat certain types of malaria), &nbsp;</li><li>&nbsp; &nbsp; Pentamidine (used to treat certain types of pneumonia), &nbsp;</li><li>&nbsp; &nbsp; Mizolastine (used to treat allergic reactions, such as hay fever), &nbsp;</li><li>&nbsp; &nbsp; Non-steroidal anti-inflammatory drugs for pain relief (e.g. ibuprofen) or high doses of acetylsalicylic acid, &nbsp;</li><li>&nbsp; &nbsp; Angiotensin converting enzyme (ACE) inhibitors (used to treat high blood pressure and heart failure), &nbsp;</li><li>&nbsp; &nbsp; Amphotericin B by injection (anti-fungal medicines), &nbsp;</li><li>&nbsp; &nbsp; Oral corticosteroids used to treat various conditions including severe asthma and rheumatoid arthritis, &nbsp;</li><li>&nbsp; &nbsp; Stimulant laxatives, &nbsp;</li><li>&nbsp; &nbsp; Baclofen (to treat muscle stiffness occurring in diseases such as multiple sclerosis), &nbsp;</li><li>&nbsp; &nbsp; Allopurinol (for treatment of gout), &nbsp;</li><li>&nbsp; &nbsp; Potassium-sparing diuretics (amiloride, spironolactone, triamterene), &nbsp;</li><li>&nbsp; &nbsp; Metformin (to treat diabetes), &nbsp;</li><li>&nbsp; &nbsp; Iodinated contrast media (used for tests involving X-rays), &nbsp;</li><li>&nbsp; &nbsp; Calcium tablets or other calcium supplements,</li><li>&nbsp; &nbsp; Ciclosporin, tacrolimus or other medicines to depress the immune system after organ transplantation, to treat autoimmune diseases, or severe rheumatic or dermatological diseases, &nbsp;</li><li>&nbsp; &nbsp; Tetracosactide (to treat Crohn&rsquo;s disease).</li></ul><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking any medicine.</p><p>&nbsp;</p><p>This medicine is not recommended during pregnancy. When a pregnancy is planned or confirmed, the switch to an alternative treatment should be initiated as soon as possible. Please tell your doctor if you are pregnant or wish to become pregnant.</p><p>&nbsp;</p><p>The active ingredient is excreted in milk. Breast-feeding is not advisable if you are taking this medicine.</p><p>&nbsp;</p><p><strong>Driving and using machines </strong></p><p>This medicine can cause side effects due to lowering of the blood pressure such as dizziness or tiredness (see section 4). These side effects are more likely to occur after initiation of the treatment and after dose increases. If this occurs, you should refrain from driving and other activities requiring alertness. However, under good control, these side effects are unlikely to occur.</p><p>&nbsp;</p><p><strong>Normalix SR contains lactose anhydrous </strong></p><p>Normalix SR contains lactose anhydrous. Each prolonged-release film-coated tablet contains 95.96 mg lactose anhydrous. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor if you are not sure.</p><p>&nbsp;</p><p>The recommended dose is one tablet each day, preferably in the morning.</p><p>&nbsp;</p><p>The tablets can be taken irrespective of meals. They should be swallowed whole with water. Do not crush or chew them.</p><p>&nbsp;</p><p>Treatment for high blood pressure is usually life-long.</p><p>&nbsp;</p><p><strong>If you take more </strong><strong>Normalix SR </strong><strong>than you should</strong></p><p>If you have taken too many tablets, contact your doctor or pharmacist immediately.&nbsp;</p><p>&nbsp;</p><p>A very large dose of Normalix SR could cause nausea (feeling sick), vomiting, low blood pressure, cramps, dizziness, drowsiness, confusion and changes in the amount of urine produced by the kidneys.</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to take </strong><strong>Normalix SR</strong></p><p>If you forget to take a dose of your medicine, take the next dose at the usual time.</p><p>&nbsp;</p><p>Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop taking </strong><strong>Normalix SR</strong></p><p>As the treatment for high blood pressure is usually life-long, you should discuss with your doctor before stopping this medicinal product.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>Stop taking the medicinal product and see a doctor immediately, if you experience any of the following side effects: </strong></p><ul><li>&nbsp; &nbsp; Angioedema and/or urticaria. Angioedema is characterised by swelling of the skin of extremities or face, swelling of the lips or tongue, swelling of the mucous membranes of the throat or airways resulting in shortness of breath or difficulty of swallowing. If this occurs, contact your doctor immediately. (Very rare) (may affect up to 1 in 10,000 people) &nbsp;</li><li>&nbsp; &nbsp; Severe skin reactions including intense skin rash, reddening of the skin over your whole body, severe itching, blistering, peeling and swelling of the skin, inflammation of mucous membranes (Stevens Johnson Syndrome) or other allergic reactions, (Very rare) (may affect up to 1 in 10,000 people) &nbsp;</li><li>&nbsp; &nbsp; Life-threatening irregular beat. (Not known) &nbsp;</li><li>&nbsp; &nbsp; Inflamed pancreas which may cause severe abdominal and back pain accompanied with feeling very unwell (Very rare) (may affect up to 1 in 10,000 people) &nbsp;</li><li>&nbsp; &nbsp; Disease of the brain caused by liver illness (Hepatic encephalopathy) (Not known) &nbsp;</li><li>&nbsp; &nbsp; Inflammation of the liver (Hepatitis) (Not known).</li></ul><p>&nbsp;</p><p><strong><em>In decreasing order of frequency, other side effects can include: </em></strong></p><p><strong>Common (may affect up to 1 in 10 people): </strong></p><ul><li>&nbsp; &nbsp; Red raised skin rash; &nbsp;</li><li>&nbsp; &nbsp; Allergic reactions, mainly dermatological, in subjects with a predisposition to allergic and asthmatic reactions.</li></ul><p><strong>Uncommon (may affect up to 1 in 100 people): </strong></p><ul><li>&nbsp; &nbsp; Vomiting; &nbsp;</li><li>&nbsp; &nbsp; Red pinpoints on skin (Purpura).</li></ul><p><strong>Rare (may affect up to 1 in 1000 people); </strong></p><ul><li>&nbsp; &nbsp; Feeling of tiredness, headache, pins and needles (paraesthesia), vertigo; &nbsp;</li><li>&nbsp; &nbsp; Gastro-intestinal disorders (such as nausea, constipation), dry mouth.</li></ul><p>&nbsp;</p><p><strong>Very rare (may affect up to 1 in 10,000 people): </strong></p><ul><li>&nbsp; &nbsp; Changes in blood cells, such as thrombocytopenia (decrease in the number of platelets which causes easy bruising and nasal bleeding), leucopenia (decrease of white blood cells which may cause unexplained fever, soreness of the throat or other flu-like symptoms &ndash; if this occurs, contact your doctor) and anaemia (decrease in red blood cells); &nbsp;</li><li>&nbsp; &nbsp; High level of calcium in blood; &nbsp;</li><li>&nbsp; &nbsp; Heart rhythm irregularities (causing palpitations, feeling of the heart pounding), low blood pressure; &nbsp;</li><li>&nbsp; &nbsp; Kidney disease (causing symptoms of tiredness, increased need to urinate, itchy skin, feeling sick, swollen extremities); &nbsp;</li><li>&nbsp; &nbsp; Abnormal hepatic function.</li></ul><p>&nbsp;</p><p><strong>Not known: </strong></p><ul><li>&nbsp; &nbsp; Fainting. &nbsp;</li><li>&nbsp; &nbsp; If you suffer from systemic lupus erythematosus (a disorder of the immune system leading to inflammation and damage to the joints, tendons and organs with symptoms including skin rashes, tiredness, loss of appetite, weight gain and joint pain), this might get worse. &nbsp;</li><li>&nbsp; &nbsp; Cases of photosensitivity reactions (change in skin appearance) after exposure to the sun or artificial UVA have also been reported. &nbsp;</li><li>&nbsp; &nbsp; Short sightedness (myopia). &nbsp;</li><li>&nbsp; &nbsp; Blurred vision. &nbsp;</li><li>&nbsp; &nbsp; Visual impairment. &nbsp;</li><li>&nbsp; &nbsp; Changes may occur in your blood and your doctor may need to give you blood tests to check your condition. The following changes in laboratory parameters may occur:</li></ul><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low potassium in the blood,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low sodium in the blood that may lead to dehydration and low blood pressure,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in uric acid, a substance which may cause or worsen gout (painful joint(s) especially in the feet),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in blood glucose levels in diabetic patients,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased levels of liver enzymes,</p><ul><li>&nbsp; &nbsp; Abnormal ECG heart tracing.</li><li>&nbsp; &nbsp; Decrease in vision or pain in your eyes due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma).</li></ul><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, healthcare provider or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not store above 30&deg;C.</p><p>Store in the original package.</p><p>Do not use this medicine after the expiry date which is stated on the package after {abbreviation used for expiry date}. The expiry date refers to the last day of that month.</p><p>Do not use this medicine if you notice any visible signs of deterioration.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is indapamide. Each prolonged-release film-coated tablet contains 1.5 mg indapamide.</p><p>&nbsp;</p><p>The other ingredients are: <em>Tablet core:</em> Povidone, Methocel, lactose anhydrous, silicified microcrystalline cellulose, magnesium stearate and colloidal silicon dioxide. <em>Tablet coat: </em>Opadry white.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Normalix SR 1.5 mg Prolonged-release Film-coated Tablets are round normal concave film-coated tablets embossed with “JI“ on one side and “75“ on the other side in aluminum foil blisters.  

Pack size: 30 Prolonged-release film-coated tablets. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder and Manufacturer</strong></p><p>Jazeera Pharmaceutical Industries<br />Al-Kharj Road<br />P.O. BOX 106229<br />Riyadh 11666, Saudi Arabia<br />Tel: + (966-11) 8107023, + (966-11) 2142472<br />Fax: + (966-11) 2078170<br />e-mail: SAPV@hikma.com</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can also help provide more information on the safety of this medicine.</p><ul><li>&nbsp; &nbsp; Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><ul><li>&nbsp; &nbsp; Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 03/2021; version number SA1.0.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">نورمالكس إس آر هي عبارة عن أقراص مغطاة بطبقة رقيقة ممتدة الإطلاق تحتوي على إينداباميد كمادة فعالة. يستخدم هذا الدواء لتقليل ارتفاع ضغط الدم (فرط ضغط الدم) لدى البالغين. إينداباميد هو مُدر للبول. تعمل معظم مُدِرَّات البول على زيادة كمية البول التي تفرزها الكلى. ومع ذلك، يختلف إينداباميد عن مُدِرَّات البول الأخرى، نظراً إلى أنه لا يسبب سوى زيادة طفيفة في كمية البول التي يتم إفرازها.</p><p>&nbsp;</p><p dir="RTL">بالإضافة إلى ذلك، يعمل إينداباميد على توسيع الأوعية الدموية، وبذلك يمر الدم من خلالها بسهولة أكبر. وهذا يساعد على خفض ضغط الدم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول نورمالكس إس آر </strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;إذا كنت تعاني من حساسية لإينداباميد أو لأي أدوية سلفوناميد الأخرى أو لأي من المواد الأخرى المستخدمة في تركيبة هذا الدواء (المذكورة في القسم 6)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;إذا كنت مصاباً بمرض كلوي شديد،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;إذا كنت مصاباً بمرض كبدي شديد أو تعاني من حالة تسمى اعتلال دماغي كبدي (مرض تنكُّسي للدماغ)،</li><li>&nbsp; &nbsp; &nbsp;إذا كان لديك انخفاض في مستويات البوتاسيوم في الدم.</li></ul><p>&nbsp;</p><p dir="RTL"><strong>الاحتياطات والتحذيرات </strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلي قبل تناول نورمالكس إس آر:</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;إذا كنت تعاني من مشاكل في الكبد،</li><li>&nbsp; &nbsp; &nbsp;إذا كنت مصاباً بمرض السكري،</li><li>&nbsp; &nbsp; &nbsp;إذا كنت تعاني من النقرس،</li><li>&nbsp; &nbsp; &nbsp;إذا كنت تعاني من أي مشاكل في نظم القلب أو مشاكل في الكلى،</li><li>&nbsp; &nbsp; &nbsp;إذا كنت بحاجة إلى اختبار للتحقق من مدى كفاءة عمل الغدة الدرقية،</li><li>&nbsp; &nbsp; &nbsp;إذا كنت تعاني من ضعف النظر أو ألم العين. قد تكون هذه أعراضاً لتراكم السوائل في الطبقة الوعائية للعين (الانصباب المشيمي) أو ارتفاع ضغط العين وقد يحدث في غضون ساعات إلى أسبوع من تناول نورمالكس إس آر. وقد يؤدي ذلك إلى الفقدان الدائم للبصر، إذا لم يتم علاجها. إذا أصبت مسبقاً بحساسية للبنسلين أو لأدوية السلفوناميد، فقد تكون أكثر عرضة للإصابة بهذا.</li></ul><p>&nbsp;</p><p dir="RTL">يجب أن تُخبر طبيبك إذا أُصبت برد فعل تحسسي للضوء.</p><p>&nbsp;</p><p dir="RTL">قد يجري لك طبيبك فحوصات الدم للتحقق من انخفاض مستويات البوتاسيوم أو الصوديوم أو ارتفاع مستويات الكالسيوم.&nbsp;</p><p>&nbsp;</p><p dir="RTL">إذا كنت تعتقد أن أياً من هذه الحالات تنطبق عليك أو لديك أي استفسارات أو شكوك بشأن تناول الدواء، يجب عليك استشارة طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي أن يدرك الرياضيون أن هذا الدواء يحتوي على مادة فعالة قد تعطي تفاعلاً إيجابياً في اختبارات المنشطات.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأدوية الأخرى ونورمالكس إس آر</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تأخذ، أخذت مؤخراً، أو قد تأخذ أية أدوية أخرى.</p><p>&nbsp;</p><p dir="RTL">يجب عدم تناول نورمالكس إس آر مع الليثيوم (يُستخدم لعلاج الاكتئاب) بسبب خطر تزايد مستويات الليثيوم في الدم.</p><p>&nbsp;</p><p dir="RTL">احرص على إخبار طبيبك إذا كنت تتناول أياً من الأدوية التالية، نظراً إلى أن الأمر قد يتطلب عناية خاصة:</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;الأدوية المستخدمة لعلاج مشاكل نظم القلب (مثل، كينيدين، هيدروكينيدين، ديسوبيراميد، أميودارون، سوتالول، إيبوتيليد، دوفيتيليد، ديجيتاليس)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;الأدوية المستخدمة في علاج الاضطرابات النفسية مثل الاكتئاب، القلق، انفصام الشخصية... (مثل، مضادات الاكتئاب ثلاثية الحلقات، العقاقير المضادة للذهان، مضادات الذهان)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;بيبريديل (يُستخدم في علاج الذبحة الصدرية، حالة تسبب ألماً في الصدر)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;سيسابريد، ديفيمانيل (يُستخدم لعلاج مشاكل الجهاز الهضمي)،</li><li>&nbsp; &nbsp; &nbsp;سبارفلوكساسين، موكسيفلوكساسين، إريثرومايسين تؤخذ عن طريق الحقن (المضادات الحيوية التي تُستخدم لعلاج العدوى)،</li><li>&nbsp; &nbsp; &nbsp;فينكامين يؤخذ عن طريق الحقن (يُستخدم في علاج الاضطرابات المعرفية المصحوبة بأعراض لدى البالغين وتشمل فقدان الذاكرة)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;هالوفانترين (عقار مضاد للطفيليات يُستخدم لعلاج أنواع معينة من الملاريا)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;بينتاميدين (يُستخدم في علاج بعض حالات الالتهاب الرئوي)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;ميزولاستين (يُستخدم في علاج ردود فعل تحسسية، مثل حمى الكلأ)،</li><li>&nbsp; &nbsp; &nbsp;أدوية مضادات الالتهاب غير الستيرويدية لتسكين الألم (مثل إيبوبروفين) أو الجرعات العالية من حمض الأسيتيل ساليسيليك،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;مثبطات الإنزيم المحول للأنجيوتنسين (المستخدم لعلاج ارتفاع ضغط الدم وفشل القلب)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;أمفوتريسين ب يؤخذ عن طريق الحقن (أدوية مضادة للفطريات)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;الستيرويدات القشرية التي تؤخذ عن طريق الفم المستخدمة في علاج حالات مختلفة منها الربو الشديد والتهاب المفاصل الروماتويدي،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;المليّنات المحفزة،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;باكلوفين (لعلاج تيبس العضلات التي تحدث في أمراض مثل حالات التصلب المتعدد)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;الألوبيورينول (لعلاج النقرس)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;مُدِرَّات البول الموفرة للبوتاسيوم (أميلوريد، سبيرونولاكتون، تريامتيرين)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;ميتفورمين (لعلاج مرض السكري)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;أوساط التباين التي تحتوي على اليود (تُستخدم للفحوصات التي تتضمن الأشعة السينية)،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;أقراص الكالسيوم أو مكملات الكالسيوم الأخرى،</li><li>&nbsp; &nbsp; &nbsp;السيكلوسبورين، تاكروليمس أو أدوية أخرى لتثبيط جهاز المناعة عقب حالات زراعة الأعضاء لعلاج الأمراض التي تؤثر على المناعة الذاتية، أو أمراض الروماتيزم الشديدة أو الأمراض الجلدية،&nbsp;</li><li>&nbsp; &nbsp; &nbsp;تتراكوساكتيد (لعلاج داء كرون).</li></ul><p dir="RTL"><strong>الحمل</strong> <strong>والرضاعة </strong></p><p dir="RTL">يرجى استشارة طبيبك أو الصيدلي إذا كنت حاملاً أو مرضعة، أو تعتقدين بأنك حامل أو تخططين لذلك قبل تناول أي دواء.</p><p>&nbsp;</p><p dir="RTL">لا يُوصى باستعمال هذا الدواء أثناء الحمل. في حال التخطيط للحمل أو ثبت وجود حمل، فإنه يجب التحول إلى أخذ علاج بديل في أقرب وقت ممكن. يرجى إخبار الطبيب إذا كنتِ حاملاً أو ترغبين في الحمل.</p><p>&nbsp;</p><p dir="RTL">تُفرز المادة الفعالة في الحليب. لا يُنصح بالرضاعة في حال تناول هذا الدواء.</p><p>&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات </strong></p><p dir="RTL">يمكن أن يسبب هذا الدواء آثاراً جانبية بسبب انخفاض ضغط الدم مثل الدوخة أو التعب (انظر القسم 4). يزداد احتمال ظهور الآثار الجانبية هذه بعد البدء في العلاج وعقب زيادة الجرعة. في حال حدوث ذلك، يجب الامتناع عن القيادة والأنشطة الأخرى التي تتطلب الانتباه. ومع ذلك، تحت السيطرة الجيدة، لا يُحتمل حدوث هذه الآثار الجانبية.</p><p>&nbsp;</p><p dir="RTL"><strong>يحتوي نورمالكس إس آر على اللاكتوز اللامائي </strong></p><p dir="RTL">يحتوي نورمالكس إس آر على اللاكتوز اللامائي. يحتوي كل قرص مغطى بطبقة رقيقة ممتد الإطلاق على 95.96 ملغم لاكتوز لامائي. إذا أخبرك طبيبك بأن لديك عدم تحمل لبعض السكريات، فتواصل مع طبيبك قبل تناول هذا المستحضر الدوائي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول هذا الدواء دائماً كما أخبرك طبيبك أو الصيدلي تماماً. تحقق من طبيبك إذا كنت غير متأكد.</p><p>&nbsp;</p><p dir="RTL">الجرعة الموصى بها هي قرص واحد يومياً، ويُفضل في الصباح.</p><p>&nbsp;</p><p dir="RTL">يمكن تناول الأقراص بغض النظر عن الوجبات. يجب بلعها بالكامل مع الماء. لا تسحقها أو تمضغها.</p><p>&nbsp;</p><p dir="RTL">يستمر علاج ارتفاع ضغط الدم عادة مدى الحياة.</p><p>&nbsp;</p><p dir="RTL"><strong>إذا تناولت </strong><strong>نورمالكس إس آر أكثر من اللازم</strong></p><p dir="RTL">إذا كنت قد تناولت الكثير من الأقراص، فاتصل بالطبيب أو الصيدلي على الفور.&nbsp;</p><p>&nbsp;</p><p dir="RTL">يمكن أن يسبب تناول جرعة كبيرة جداً من نورمالكس إس آر الغثيان (الشعور بالإعياء)، القيء، انخفاض ضغط الدم، التشنجات، الدوخة، النعاس، الارتباك والتغيرات في كمية البول التي تفرزها الكلى.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا نسيت تناول </strong><strong>نورمالكس إس آر</strong></p><p dir="RTL">إذا نسيت تناول جرعة من دوائك، فتناول الجرعة التالية في الوقت المعتاد.</p><p>&nbsp;</p><p dir="RTL">لا تقم بتناول جرعة مضاعفة لتعويض الجرعة المفقودة.</p><p>&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن تناول </strong><strong>نورمالكس إس آر</strong></p><p dir="RTL">نظراً إلى أن العلاج من ارتفاع ضغط الدم يستمر عادة مدى الحياة، يجب عليك مناقشة ذلك مع طبيبك قبل التوقف عن تناول هذا المستحضر الدوائي.</p><p>&nbsp;</p><p dir="RTL">إذا كان لديك أية أسئلة إضافية حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثاراً جانبية، إلا أنه ليس بالضرورة أن تحدث لدى الجميع.</p><p>&nbsp;</p><p dir="RTL"><strong>توقف عن تناول المستحضر الدوائي وتوجه للطبيب فوراً إذا أصبت بأي من الآثار الجانبية التالية: </strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;وذمة وعائية و/أو الشرى. تتصف الوذمة الوعائية بتورم الجلد في الأطراف أو الوجه، تورم الشفتين أو اللسان، تورم الأغشية المخاطية للحلق أو الممرات الهوائية ما يؤدي إلى ضيق التنفس أو صعوبة البلع. في حال حدوث ذلك، اتصل بطبيبك فوراً. (نادرة جداً) (قد تؤثر على ما يصل إلى شخص واحد من بين 10000 شخص)&nbsp;</li><li>&nbsp; &nbsp; ردود فعل جلدية شديدة تشمل طفح جلدي شديد، احمرار الجلد في جميع أنحاء الجسم، حكة شديدة، تقرح، تقشّر وتورم الجلد، التهاب الأغشية المخاطية (متلازمة ستيفنز جونسون) أو ردود فعل تحسسية أخرى، (نادرة جداً) (قد تؤثر على ما يصل إلى شخص واحد من بين 10000 شخص)&nbsp;</li><li>&nbsp; &nbsp; &nbsp;نبضات غير منتظمة مهددة للحياة. (غير معروفة)&nbsp;</li><li>&nbsp; &nbsp; &nbsp;التهاب البنكرياس الذي قد يسبب ألماً شديداً في البطن وألماً بالظهر المصاحب بشعور التوعك الشديد (نادرة جداً) (قد تؤثر على ما يصل إلى شخص واحد من بين 10000 شخص)&nbsp;</li><li>&nbsp; &nbsp; &nbsp;مرض في الدماغ بسبب مرض الكبد (اعتلال دماغي كبدي) (غير معروفة)&nbsp;</li><li>&nbsp; &nbsp; &nbsp;التهاب الكبد (غير معروفة).</li></ul><p dir="RTL"><strong><em>يمكن أن تشمل الآثار الجانبية الأخرى، وذلك حسب الترتيب التنازلي من حيث التكرار: </em></strong></p><p dir="RTL"><strong>&nbsp;شائعة (قد تؤثر على ما يصل إلى شخص واحد من بين 10 أشخاص): </strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;طفح جلدي يصاحبه احمرار شديد؛&nbsp;</li><li>&nbsp; &nbsp; &nbsp;ردود فعل تحسسية، الأمراض الجلدية بشكل أساسي، لدى المرضى الذين تعرضوا لحساسية وردود فعل تحسسية للربو.</li></ul><p>&nbsp;</p><p dir="RTL"><strong>غير شائعة (قد تؤثر على ما يصل إلى شخص واحد من بين 100 شخص): </strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;القيء؛&nbsp;</li><li>&nbsp; &nbsp; &nbsp;بقع حمراء على الجلد (الفرفرية).</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;نادرة (قد تؤثر على ما يصل إلى شخص واحد من كل 1000 شخص)؛ </strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;شعور بالتعب، الصداع، الوخز والتنميل (مَذَل)، دوار؛</li><li>&nbsp; &nbsp; &nbsp;اضطرابات الجهاز الهضمي (مثل الغثيان، الإمساك)، جفاف الفم.</li></ul><p>&nbsp;</p><p dir="RTL"><strong>&nbsp;نادرة جداً (قد تؤثر على ما يصل إلى شخص واحد من كل 10000 شخص): </strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;تغيرات في خلايا الدم، مثل قلة الصفيحات (انخفاض في عدد الصفائح الدموية التي تسبب سهولة التعرض للكدمات ونزيفاً في الأنف)، قلة الكريات البيضاء (انخفاض خلايا الدم البيضاء التي قد تسبب حمى مجهولة السبب، تقرحاً في الحلق أو أعراضاً أخرى شبيهة بالإنفلونزا - إذا حدث ذلك، فاتصل بطبيبك) وفقر الدم (انخفاض في خلايا الدم الحمراء)؛&nbsp;</li><li>&nbsp; &nbsp; &nbsp;ارتفاع مستوى الكالسيوم في الدم؛&nbsp;</li><li>&nbsp; &nbsp; &nbsp;اضطرابات في نظم القلب (التي تسبب خفقان القلب، الشعور بدقات القلب)، انخفاض ضغط الدم؛&nbsp;</li><li>&nbsp; &nbsp; &nbsp;أمراض الكلى (تسبب أعراض التعب، زيادة الحاجة إلى التبول، حكة الجلد، الشعور بالإعياء، تورم الأطراف)؛&nbsp;</li><li>&nbsp; &nbsp; &nbsp;اضطراب في وظائف الكبد.</li></ul><p>&nbsp;</p><p dir="RTL"><strong>غير معروفة: </strong></p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;الإغماء.&nbsp;</li><li>&nbsp; &nbsp; &nbsp;إذا كنت تعاني من الذئبة الحُمامية المجموعية (اضطراب في الجهاز المناعي يؤدي إلى التهاب وتلف المفاصل والأوتار والأعضاء مع أعراض تشمل طفح جلدي، تعب، فقدان الشهية، زيادة الوزن وآلام المفاصل)، قد يزداد الأمر سوءاً.&nbsp;</li><li>&nbsp; &nbsp; &nbsp;تم الإبلاغ أيضاً عن حالات ردود فعل تحسسية للضوء (تغير في مظهر الجلد) بعد التعرض لأشعة الشمس أو لضوء الأشعة فوق البنفسجية الاصطناعي.&nbsp;</li><li>&nbsp; &nbsp; &nbsp;قصر النظر (ضعف البصر).&nbsp; &nbsp;</li><li>&nbsp; &nbsp; &nbsp;تغيم الرؤية.&nbsp;</li><li>&nbsp; &nbsp; &nbsp;ضعف البصر.&nbsp;</li><li>&nbsp; &nbsp; &nbsp;قد تحدث تغييرات في دمك وقد يحتاج طبيبك إلى إجراء فحوصات دم لك للتحقق من حالتك. قد تحدث التغييرات التالية في المؤشرات المختبرية:</li></ul><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض البوتاسيوم في الدم،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض الصوديوم في الدم الذي قد يؤدي إلى الجفاف وانخفاض ضغط الدم،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في حمض اليوريك، وهي مادة قد تسبب النقرس أو تفاقمه (آلام في المفاصل خصوصاً في القدمين)،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات الجلوكوز في الدم لدى مرضى السكري،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات إنزيمات الكبد،</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;تتبع مخطط كهربية القلب غير الطبيعي.&nbsp;</li><li>&nbsp; &nbsp; &nbsp;ضعف النظر أو ألم في عينيك بسبب ارتفاع الضغط (علامات محتملة لتراكم السوائل في طبقة الأوعية الدموية للعين (الانصباب المشيمي) أو زَرَقُ انسداد الزاوية الحاد).</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">يرجى الاتصال بالطبيب، مقدم الرعاية الصحية، أو الصيدلي في حال أصبحت أي من الآثار الجانبية أكثر سوءاً أو في حال لاحظت أية آثار جانبية لم تذكر في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال.</p><p dir="RTL">لا يحفظ عند درجة حرارة أعلى من 30&deg; مئوية.</p><p dir="RTL">يحفظ داخل العبوة الأصلية.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الخارجية بعد &ldquo;EXP&rdquo;. يشير تاريخ الانتهاء إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت أي علامات تلف واضحة عليه.</p><p dir="RTL">لا تتخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه الإجراءات ستساعد في الحفاظ على سلامة البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي إينداباميد. يحتوي كل قرص مغطى بطبقة رقيقة ممتد الإطلاق على 1.5 ملغم إينداباميد.</p><p>&nbsp;</p><p dir="RTL">المواد الأخرى المستخدمة في التركيبة التصنيعية هي:<em> </em><em>لب</em><em> القرص:</em> بوﭭيدون، &nbsp;ميثوسيل، لاكتوز لامائي، &nbsp;سيلليلوز بلوري مكروي معالج بالسيليكا، ستيرات المغنيسيوم وثاني أكسيد السيليكون الغروي. <em>غلاف القرص: </em>أوبادري أبيض.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">نورمالكس إس آر 1.5 ملغم أقراص مغطاة بطبقة رقيقة ممتدة الإطلاق هي أقراص دائرية مقعرة مغطاة بطبقة رقيقة، منقوش &ldquo;JI&rdquo; على أحد الجانبين &ldquo;75&rdquo;على الجانب الآخر في أشرطة من رقائق الألومنيوم.&nbsp;</p><p style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">حجم العبوة: 30 قرص مغطى بطبقة رقيقة ممتد الإطلاق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اسم وعنوان مالك رخصة التسويق والشركة المصنعة </strong></p><p dir="RTL">شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد 106229<br />الرياض 11666، المملكة العربية السعودية<br />هاتف: 8107023 (11-966) +، 2142472 (11-966) +<br />فاكس: 2078170 (11-966) +<br />البريد الإلكتروني: SAPV@hikma.com</p><p>&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">تحدث إلى الطبيب، الصيدلي، أو الممرض إذا عانيت من أية آثار جانبية. وذلك يشمل أي آثار جانبية لم يتم ذكرها في هذه النشرة. كما أنه يمكنك الإبلاغ عن هذه الآثار مباشرةً (انظر التفاصيل المذكورة أدناه). من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة بتوفير معلومات مهمة عن سلامة الدواء.</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;المملكة العربية السعودية</li></ul><p dir="RTL">المركز الوطني للتيقظ الدوائي</p><p dir="RTL">مركز الاتصال الموحد: 19999</p><p dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL">&nbsp;</p><ul dir="rtl"><li>&nbsp; &nbsp; &nbsp;دول الخليج العربي الأخرى</li></ul><p dir="RTL">الرجاء الاتصال بالجهات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ 2021/03، رقم النسخة SA1.0.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Normalix SR 1.5 mg Prolonged-release Film-coated Tablets. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each prolonged-release Film-coated Tablet contains 1.5 mg indapamide.

Excipient with known effect: Each prolonged-release film-coated tablet contains 95.96 mg lactose anhydrous.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prolonged-release film-coated tablets. 

Round normal concave film-coated tablets embossed with “JI“ on one side and “75“ on the other side. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Normalix SR is indicated in essential hypertension in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong></p><p>One tablet per 24 hours, preferably in the morning, to be swallowed whole with water and not chewed.</p><p>&nbsp;</p><p>At higher doses the antihypertensive action of indapamide is not enhanced but the saluretic effect is increased.</p><p>&nbsp;</p><p><u>Special populations</u></p><p><em>Renal impairment (see sections 4.3 and 4.4):</em></p><p>In severe renal failure (creatinine clearance below 30 ml/min), treatment is contraindicated.</p><p>Thiazide and related diuretics are fully effective only when renal function is normal or only minimally impaired.</p><p>&nbsp;</p><p><em>Hepatic impairment (see sections 4.3 and 4.4):</em></p><p>In severe hepatic impairment, treatment is contraindicated.</p><p>&nbsp;</p><p><em>Elderly (see section 4.4):</em></p><p>In the elderly, the plasma creatinine must be adjusted in relation to age, weight and gender. Elderly patients can be treated with Normalix SR when renal function is normal or only minimally impaired.</p><p>&nbsp;</p><p><em>Paediatric population:</em></p><p>The safety and efficacy of indapamide in children and adolescents have not been established. No data are available.</p><p>&nbsp;</p><p><strong>Method of administration</strong></p><p>Oral use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Hypersensitivity to the active substance, to other sulfonamides or to any of the excipients listed in section 6.1.
•	Severe renal failure.
•	Hepatic encephalopathy or severe impairment of liver function.
•	Hypokalaemia.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Special warnings</strong></p><p>When liver function is impaired, thiazide-related diuretics may cause hepatic encephalopathy, particularly in case of electrolyte imbalance. Administration of the diuretic must be stopped immediately if this occurs.</p><p>&nbsp;</p><p>Photosensitivity:</p><p>Cases of photosensitivity reactions have been reported with thiazides and thiazide-related diuretics (see section 4.8). If photosensitivity reaction occurs during treatment, it is recommended to stop the treatment. If a re-administration of the diuretic is deemed necessary, it is recommended to protect exposed areas to the sun or to artificial UVA.</p><p>&nbsp;</p><p>Excipients:</p><p>Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p><p>&nbsp;</p><p><strong>Special precautions for use</strong></p><p><em>Water and electrolyte balance:</em></p><ul><li>&nbsp;Plasma sodium:</li></ul><p>This must be measured before starting treatment, then at regular intervals subsequently. The fall in plasma sodium may be asymptomatic initially and regular monitoring is therefore essential, and should be even more frequent in the elderly and cirrhotic patients (see sections 4.8 and 4.9). Any diuretic treatment may cause hyponatraemia, sometimes with very serious consequences. Hyponatraemia with hypovolaemia may be responsible of dehydration and orthostatic hypotension. Concomitant loss of chloride ions may lead to secondary compensatory metabolic alkalosis: the incidence and degree of this effect are slight.</p><p>&nbsp;</p><ul><li>&nbsp;Plasma potassium:</li></ul><p>Potassium depletion with hypokalaemia is the major risk of thiazide and related diuretics. The risk of onset of hypokalaemia (&lt; 3.4 mmol/l) must be prevented in certain high risk populations, i.e. the elderly, malnourished and/or polymedicated, cirrhotic patients with oedema and ascites, coronary artery disease and cardiac failure patients. In this situation, hypokalaemia increases the cardiac toxicity of digitalis preparations and the risks of arrhythmias.</p><p>&nbsp;</p><p>Individuals with a long QT interval are also at risk, whether the origin is congenital or iatrogenic. Hypokalaemia, as well as bradycardia, is then a predisposing factor to the onset of severe arrhythmias, in particular, potentially fatal torsades de pointes.</p><p>&nbsp;</p><p>More frequent monitoring of plasma potassium is required in all the situations indicated above. The first measurement of plasma potassium should be obtained during the first week following the start of treatment.</p><p>&nbsp;</p><p>Detection of hypokalaemia requires its correction.</p><p>&nbsp;</p><ul><li>&nbsp;Plasma calcium:</li></ul><p>Thiazide and related diuretics may decrease urinary calcium excretion and cause a slight and transitory rise in plasma calcium. Frank hypercalcaemia may be due to previously unrecognised hyperparathyroidism.</p><p>&nbsp;</p><p>Treatment should be withdrawn before the investigation of parathyroid function.</p><p>&nbsp;</p><p><em>Blood glucose:</em></p><p>Monitoring of blood glucose is important in diabetics, in particular in the presence of hypokalaemia.</p><p>&nbsp;</p><p><em>Uric acid:</em></p><p>Tendency to gout attacks may be increased in hyperuricaemic patients.</p><p>&nbsp;</p><p><em>Renal function and diuretics:</em></p><p>Thiazide and related diuretics are fully effective only when renal function is normal or only minimally impaired (plasma creatinine below levels of the order of 25 mg/l, i.e. 220 &micro;mol/l in an adult). In the elderly, this plasma creatinine must be adjusted in relation to age, weight and gender.</p><p>&nbsp;</p><p>Hypovolaemia, secondary to the loss of water and sodium induced by the diuretic at the start of treatment causes a reduction in glomerular filtration. This may lead to an increase in blood urea and plasma creatinine. This transitory functional renal insufficiency is of no consequence in individuals with normal renal function but may worsen preexisting renal insufficiency.</p><p>&nbsp;</p><p><em>Athletes:</em></p><p>The attention of athletes is drawn to the fact that this medicinal product contains a drug substance, which may give a positive reaction in doping tests.</p><p>&nbsp;</p><p><em>Choroidal effusion, acute myopia and secondary angle-closure glaucoma:</em></p><p>Sulfonamide or sulfonamide derivative drugs can cause an idiosyncratic reaction resulting in choroidal effusion with visual field defect, transient myopia and acute angle-closure glaucoma. Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation. Untreated acute angle-closure glaucoma can lead to permanent vision loss. The primary treatment is to discontinue drug intake as rapidly as possible. Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled. Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Combinations that are not recommended:</strong></p><p><u>Lithium:</u></p><p>Increased plasma lithium with signs of overdosage, as with a salt-free diet (decreased urinary lithium excretion). However, if the use of diuretics is necessary, careful monitoring of plasma lithium and dose adjustment are required.</p><p>&nbsp;</p><p><strong>Combinations requiring precautions for use:</strong></p><p><u>Torsades de pointes-inducing drugs:</u></p><ul><li>&nbsp; &nbsp; Class Ia antiarrhythmics (quinidine, hydroquinidine, disopyramide),</li><li>&nbsp; &nbsp; Class III antiarrhythmics (amiodarone, sotalol, dofetilide, ibutilide),</li><li>&nbsp; &nbsp; Some antipsychotics:</li></ul><p>Phenothiazines (chlorpromazine, cyamemazine, levomepromazine, thioridazine, trifluoperazine),</p><p>&nbsp;</p><p>Benzamides (amisulpride, sulpiride, sultopride, tiapride)</p><p>&nbsp;</p><p>Butyrophenones (droperidol, haloperidol)</p><p>&nbsp;</p><p>Others: bepridil, cisapride, diphemanil, erythromycin IV, halofantrine, mizolastine, pentamidine, sparfloxacin, moxifloxacin, vincamine IV.</p><p>&nbsp;</p><p>Increased risk of ventricular arrhythmias, particularly torsades de pointes (hypokalaemia is a risk factor).</p><p>&nbsp;</p><p>Monitor for hypokalaemia and correct, if required, before introducing this combination. Clinical, plasma electrolytes and ECG monitoring.</p><p>&nbsp;</p><p><em>Use substances which do not have the disadvantage of causing torsades de pointes in the presence of hypokalaemia.</em></p><p>&nbsp;</p><p><u>N.S.A.I.Ds. (systemic route) including COX-2 selective inhibitors, high dose salicylic acid (&ge; 3 g/day):</u></p><p>Possible reduction in the antihypertensive effect of indapamide.</p><p>&nbsp;</p><p>Risk of acute renal failure in dehydrated patients (decreased glomerular filtration). Hydrate the patient; monitor renal function at the start of treatment.</p><p>&nbsp;</p><p><u>Angiotensin converting enzyme (A.C.E.) inhibitors:</u></p><p>Risk of sudden hypotension and/or acute renal failure when treatment with an A.C.E. is initiated in the presence of preexisting sodium depletion (particularly in patients with renal artery stenosis).</p><p>&nbsp;</p><p><em>In hypertension, when prior diuretic treatment may have caused sodium depletion, it is necessary:</em></p><ul><li>&nbsp; &nbsp; Either to stop the diuretic 3 days before starting treatment with the A.C.E. inhibitor, and restart a hypokalaemic diuretic if necessary;</li><li>&nbsp; &nbsp; Or give low initial doses of the A.C.E. inhibitor and increase the dose gradually.</li></ul><p><em>In congestive heart failure</em>, start with a very low dose of A.C.E. inhibitor, possibly after a reduction in the dose of the concomitant hypokalaemic diuretic.</p><p>&nbsp;</p><p><em>In all cases,</em> monitor renal function (plasma creatinine) during the first weeks of treatment with an A.C.E. inhibitor.</p><p>&nbsp;</p><p><u>Other compounds causing hypokalaemia: amphotericin B (IV), gluco- and mineralo-corticoids (systemic route), tetracosactide, stimulant laxatives:</u></p><p>Increased risk of hypokalaemia (additive effect).</p><p>&nbsp;</p><p>Monitoring of plasma potassium and correction if required. Must be particularly borne in mind in case of concomitant digitalis treatment. Use non-stimulant laxatives.</p><p>&nbsp;</p><p><u>Baclofen:</u></p><p>Increased antihypertensive effect.</p><p>&nbsp;</p><p>Hydrate the patient; monitor renal function at the start of treatment.</p><p>&nbsp;</p><p><u>Digitalis preparations:</u></p><p>Hypokalaemia predisposing to the toxic effects of digitalis.</p><p>Monitoring of plasma potassium and ECG and, if necessary, adjust the treatment.</p><p>&nbsp;</p><p><strong>Combinations requiring special care:</strong></p><p><u>Allopurinol:</u></p><p>Concomitant treatment with indapamide may increase the incidence of hypersensitivity reactions to allopurinol.</p><p>&nbsp;</p><p><strong>Combinations to be taken into consideration:</strong></p><p><u>Potassium-sparing diuretics (amiloride, spironolactone, triamterene):</u></p><p>Whilst rational combinations are useful in some patients, hypokalaemia or hyperkalaemia (particularly in patients with renal failure or diabetes) may still occur. Plasma potassium and ECG should be monitored and, if necessary, treatment reviewed.</p><p>&nbsp;</p><p><u>Metformin:</u></p><p>Increased risk of metformin induced lactic acidosis due to the possibility of functional renal failure associated with diuretics and more particularly with loop diuretics. Do not use metformin when plasma creatinine exceeds 15 mg/l (135 &micro;mol/l) in men and 12 mg/l (110 &micro;mol/l) in women.</p><p>&nbsp;</p><p><u>Iodinated contrast media:</u></p><p>In the presence of dehydration caused by diuretics, increased risk of acute renal failure, in particular when large doses of iodinated contrast media are used.</p><p>&nbsp;</p><p>Rehydration before administration of the iodinated compound.</p><p>&nbsp;</p><p><u>Imipramine-like antidepressants, neuroleptics:</u></p><p>Antihypertensive effect and increased risk of orthostatic hypotension increased (additive effect).</p><p>&nbsp;</p><p><u>Calcium (salts):</u></p><p>Risk of hypercalcaemia resulting from decreased urinary elimination of calcium.</p><p>&nbsp;</p><p><u>Ciclosporin, tacrolimus:</u></p><p>Risk of increased plasma creatinine without any change in circulating ciclosporin levels, even in the absence of water/sodium depletion.</p><p>&nbsp;</p><p><u>Corticosteroids, tetracosactide (systemic route):</u></p><p>Decreased antihypertensive effect (water/sodium retention due to corticosteroids).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>There are no or limited amount of data (less than 300 pregnancy outcomes) from the use of indapamide in pregnant women. Prolonged exposure to thiazide during the third trimester of pregnancy can reduce maternal plasma volume as well as uteroplacental blood flow, which may cause a foeto-placental ischaemia and growth retardation.</p><p>&nbsp;</p><p>Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3).</p><p>&nbsp;</p><p>As a precautionary measure, it is preferable to avoid the use of Indapamide during pregnancy.</p><p>&nbsp;</p><p><strong>Breast-feeding</strong></p><p>There is insufficient information on the excretion of indapamide/metabolites in human milk. Hypersensitivity to sulfonamide-derived medicines and hypokalaemia might occur. A risk to the newborns/infants cannot be excluded.</p><p>&nbsp;</p><p>Indapamide is closely related to thiazide diuretics which have been associated, during breast-feeding, with decrease or even suppression of milk lactation.</p><p>&nbsp;</p><p>Indapamide should not be used during breast-feeding.</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>Reproductive toxicity studies showed no effect on fertility in female and male rats (see section 5.3). No effects on human fertility are anticipated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Indapamide does not affect vigilance but different reactions in relation with the decrease in blood pressure may occur in individual cases, especially at the start of the treatment or when another antihypertensive agent is added.</p><p><strong>&nbsp;</strong></p><p>As a result the ability to drive vehicles or to operate machinery may be impaired.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Summary of safety profile</strong></p><p>The most commonly reported adverse reactions are hypersensitivity reactions, mainly dermatological, in subjects with a predisposition to allergic and asthmatic reactions and maculopapular rashes.</p><p>&nbsp;</p><p>During clinical trials, hypokalaemia (plasma potassium &lt;3.4 mmol/l) was seen in 10 % of patients and &lt; 3.2 mmol/l in 4 % of patients after 4 to 6 weeks treatment. After 12 weeks treatment, the mean fall in plasma potassium was 0.23 mmol/l.</p><p>The majority of adverse reactions concerning clinical or laboratory parameters are dose-dependent.</p><p>&nbsp;</p><p><strong>Tabulated summary of adverse reactions</strong></p><p>The following undesirable effects have been observed with indapamide during treatment ranked under the following frequency:</p><p>Very common (&ge; 1/10); common (&ge; 1/100 to &lt;1/10); uncommon (&ge; 1/1,000 to &lt; 1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&ge;1/100,000 to &lt;1/10,000), not known (cannot be estimated from the available data).</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>MedDRA</strong></p><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Undesirable Effects</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p><strong>Blood and the lymphatic System Disorders</strong></p></td><td style="vertical-align:top"><p>Agranulocytosis</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Aplastic anaemia</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Haemolytic anaemia</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Leucopenia</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Metabolism and Nutrition Disorders</strong></p></td><td style="vertical-align:top"><p>Hypercalcaemia</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Potassium depletion with hypokalaemia, particularly serious in certain high risk populations (see section 4.4)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hyponatraemia (see section 4.4)</p></td><td style="vertical-align:top"><p>Not know</p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p><strong>Nervous System disorders</strong></p></td><td style="vertical-align:top"><p>Vertigo</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Fatigue</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Paraesthesia</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Syncope</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td><td style="vertical-align:top"><p>Myopia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Blurred vision</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Visual impairment</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Choroidal effusion</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Cardiac Disorders</strong></p></td><td style="vertical-align:top"><p>Arrhythmia</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Torsade de pointes (potentially fatal) (see sections 4.4 and 4.5)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p><strong>Vascular Disorders</strong></p></td><td style="vertical-align:top"><p>Hypotension</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Nausea</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Constipation</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Dry mouth</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Pancreatitis</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Hepatobiliary Disorders</strong></p></td><td style="vertical-align:top"><p>Abnormal hepatic function</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Possibility of onset of hepatic encephalopathy in case of hepatic insufficiency (see sections 4.3 and 4.4)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hepatitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="9" style="vertical-align:top"><p><strong>Skin and Subcutaneous Tissue Disorder</strong></p></td><td style="vertical-align:top"><p>Hypersensitivity reactions</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Maculopapular rashes</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Purpura</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Angioedema</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Urticaria</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Toxic epidermal necrolysis</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Stevens-Johnson Syndrome</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Possible worsening of pre-existing acute disseminated lupus erythematosus</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Photosensitivity reactions (see section 4.4)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and Urinary Disorders</strong></p></td><td style="vertical-align:top"><p>Renal failure</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p><strong>Investigations</strong></p></td><td style="vertical-align:top"><p>Electrocardiogram QT prolonged (see sections 4.4 and 4.5)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Blood glucose increased (see section 4.4)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Blood uric acid increased (see section 4.4)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Elevated liver enzyme levels</p></td><td style="vertical-align:top"><p>Not known</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Description of selected adverse reactions</u></p><p>Cases of choroidal effusion with visual field defect have been reported after the use of thiazide and thiazide-like diuretics. If cases are to be reported for these substances in the future, the appropriate procedure should be used to update the product information accordingly.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><ul><li>&nbsp; &nbsp; Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><ul><li>&nbsp; &nbsp; Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms</strong></p><p>Indapamide has been found free of toxicity at up to 40 mg, i.e. 27 times the therapeutic dose.</p><p>Signs of acute poisoning take the form above all of water/electrolyte disturbances (hyponatraemia, hypokalaemia). Clinically, possibility of nausea, vomiting, hypotension, cramps, vertigo, drowsiness, confusion, polyuria or oliguria possibly to the point of anuria (by hypovolaemia).</p><p>&nbsp;</p><p><strong>Management</strong></p><p>Initial measures involve the rapid elimination of the ingested substance(s) by gastric wash-out and/or administration of activated charcoal, followed by restoration of water/electrolyte balance to normal in a specialised centre.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Sulfonamides, plain</p><p>&nbsp;</p><p>ATC code: C 03 BA 11</p><p><strong>&nbsp;</strong></p><p><strong>Mechanism of action</strong></p><p>Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action.</p><p>&nbsp;</p><p><strong>Pharmacodynamic effects</strong></p><p>Phase II and III studies using monotherapy have demonstrated an antihypertensive effect lasting 24 hours. This was present at doses where the diuretic effect was of mild intensity.</p><p>&nbsp;</p><p>The antihypertensive activity of indapamide is related to an improvement in arterial compliance and a reduction in arteriolar and total peripheral resistance.</p><p>&nbsp;</p><p>Indapamide reduces left ventricular hypertrophy.</p><p>&nbsp;</p><p>Thiazide and related diuretics have a plateau therapeutic effect beyond a certain dose, while adverse effects continue to increase. The dose should not be increased if treatment is ineffective.</p><p>&nbsp;</p><p>It has also been shown, in the short-, mid- and long-term in hypertensive patients, that indapamide:</p><ul><li>&nbsp; &nbsp;Does not interfere with lipid metabolism: triglycerides, LDL-cholesterol and HDL-cholesterol;</li><li>&nbsp; &nbsp;Does not interfere with carbohydrate metabolism, even in diabetic hypertensive patients.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Indapamide 1.5 mg is supplied in a prolonged release dosage based on a matrix system in which the drug substance is dispersed within a support which allows sustained release of indapamide.</p><p>&nbsp;</p><p><strong>Absorption:</strong></p><p>The fraction of indapamide released is rapidly and totally absorbed via the gastrointestinal digestive tract.</p><p>&nbsp;</p><p>Eating slightly increases the rapidity of absorption but has no influence on the amount of the drug absorbed.</p><p>&nbsp;</p><p>Peak serum level following a single dose occurs about 12 hours after ingestion, repeated administration reduces the variation in serum levels between 2 doses. Intra-individual variability exists.</p><p>&nbsp;</p><p><strong>Distribution:</strong></p><p>Binding of indapamide to plasma proteins is 79%.</p><p>&nbsp;</p><p>The plasma elimination half-life is 14 to 24 hours (mean 18 hours).</p><p>&nbsp;</p><p>Steady state is achieved after 7 days.</p><p>&nbsp;</p><p>Repeated administration does not lead to accumulation.</p><p>&nbsp;</p><p><strong>Metabolism:</strong></p><p>Elimination is essentially urinary (70% of the dose) and faecal (22%) in the form of inactive metabolites.</p><p>&nbsp;</p><p><strong>High risk individuals:</strong></p><p>Pharmacokinetic parameters are unchanged in renal failure patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Indapamide has been tested negative concerning mutagenic and carcinogenic properties.</p><p>&nbsp;</p><p>The highest doses administered orally to different animal species (40 to 8000 times the therapeutic dose) have shown an exacerbation of the diuretic properties of indapamide. The major symptoms of poisoning during acute toxicity studies with indapamide administered intravenously or intraperitoneally were related to the pharmacological action of indapamide, i.e. bradypnoea and peripheral vasodilation.</p><p>&nbsp;</p><p>Reproductive toxicity studies have not shown embryotoxicity and teratogenicity.</p><p>&nbsp;</p><p>Fertility was not impaired either in male or in female rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Tablet core:</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Povidone &nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Methocel &nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Lactose anhydrous &nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Silicified microcrystalline cellulose &nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Magnesium stearate &nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Colloidal silicon dioxide</p><p><em>&nbsp;</em></p><p><em>Tablet coat: </em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Opadry white</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>&nbsp;</p><p>Store in the original package.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminum foil blisters.</p><p>&nbsp;</p><p>Pack size: 30 Prolonged-release film-coated tablets. &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Al-Kharj Road 
P.O. BOX 106229
Riyadh 11666, Saudi Arabia
Tel: + (966-11) 8107023, + (966-11) 2142472
Fax: + (966-11) 2078170
e-mail: SAPV@hikma.com 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                08 March 2021 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>